Swiss National Bank Boosts Holdings in IQVIA Holdings Inc. (NYSE:IQV)

Swiss National Bank boosted its holdings in shares of IQVIA Holdings Inc. (NYSE:IQV) by 0.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 540,780 shares of the medical research company’s stock after acquiring an additional 1,900 shares during the period. Swiss National Bank owned 0.30% of IQVIA worth $128,149,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Versant Capital Management Inc lifted its position in IQVIA by 733.3% during the 2nd quarter. Versant Capital Management Inc now owns 125 shares of the medical research company’s stock valued at $26,000 after acquiring an additional 110 shares during the period. Opal Wealth Advisors LLC bought a new stake in IQVIA during the 2nd quarter valued at about $27,000. Capital Performance Advisors LLP bought a new stake in IQVIA during the 3rd quarter valued at about $27,000. Park Place Capital Corp bought a new stake in IQVIA during the 3rd quarter valued at about $28,000. Finally, Itau Unibanco Holding S.A. bought a new stake in IQVIA during the 2nd quarter valued at about $29,000. 89.62% of the stock is owned by hedge funds and other institutional investors.

IQVIA Stock Performance

NYSE IQV opened at $191.19 on Tuesday. The business has a 50-day moving average price of $225.96 and a 200-day moving average price of $228.02. The firm has a market cap of $34.70 billion, a price-to-earnings ratio of 25.09, a price-to-earnings-growth ratio of 1.98 and a beta of 1.51. IQVIA Holdings Inc. has a twelve month low of $187.62 and a twelve month high of $261.73. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 1.76.

Insiders Place Their Bets

In other IQVIA news, insider Eric Sherbet sold 1,300 shares of the stock in a transaction that occurred on Tuesday, August 27th. The shares were sold at an average price of $246.33, for a total transaction of $320,229.00. Following the completion of the sale, the insider now directly owns 19,536 shares of the company’s stock, valued at $4,812,302.88. This trade represents a 6.24 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 1.60% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

IQV has been the subject of a number of analyst reports. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of IQVIA from $270.00 to $265.00 and set a “buy” rating for the company in a research note on Friday, November 1st. JPMorgan Chase & Co. reduced their price target on shares of IQVIA from $279.00 to $240.00 and set an “overweight” rating for the company in a research note on Tuesday, November 5th. UBS Group lifted their price target on shares of IQVIA from $295.00 to $300.00 and gave the stock a “buy” rating in a research note on Tuesday, July 23rd. Barclays reduced their price target on shares of IQVIA from $260.00 to $255.00 and set an “overweight” rating for the company in a research note on Friday, November 1st. Finally, Redburn Atlantic assumed coverage on shares of IQVIA in a research note on Monday, October 14th. They issued a “buy” rating and a $276.00 price target for the company. Five equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $259.13.

IQVIA Company Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.